Owner AstraZeneca AB

Inventors Johnstone, Craig; Poyser, Jeffrey, Philip; Faull, Alan; Morley, Andrew

Agent Freehills

Pub. Number AU-B-2002355245

PCT Number PCT/SE02/01403

PCT Pub. Number WO2003/010158

Priority 0102616-0 25.07.01 SE

Filing date 19 July 2002

Wipo publication date 17 February 2003

Acceptance publication date 15 May 2008

C07D 333/38 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61K 31/4178 (2006.01)

A61K 31/42 (2006.01) - Oxazoles

A61K 31/4245 (2006.01) - Oxadiazoles

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/433 (2006.01) - Thiadiazoles

A61K 31/4436 (2006.01)

A61K 31/4439 (2006.01)

A61K 31/4535 (2006.01)

A61K 31/4545 (2006.01)

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/5377 (2006.01)

A61K 31/5383 (2006.01)

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 31/553 (2006.01) - having at least one nitrogen and at least one oxygen as ring hetero atoms, e.g. loxapine, staurosporine

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents